Literature DB >> 2012090

Reversal of cardiac dysfunction secondary to type 1 primary hyperoxaluria after combined liver-kidney transplantation.

R A Rodby1, T S Tyszka, J W Williams.   

Abstract

A 23-year-old man with type 1 primary hyperoxaluria, renal failure, and oxalosis developed a severe cardiomyopathy while awaiting combined liver-kidney transplantation. This manifested as radiographic cardiomegaly, a dilated hypokinetic left ventricle with a decreased ejection fraction, ventricular arrhythmias, and cardiac uptake on bone scanning. On liver and kidney transplantation, these abnormalities markedly improved and/or reversed. The cardiac size almost normalized, the left ventricular ejection fraction increased from 20% to 34%, the ventricular arrhythmias resolved, and the cardiac uptake on bone scanning disappeared. This coincided with normalization of oxalate production and excretion. Severe cardiac involvement secondary to oxalosis in patients with primary hyperoxaluria may improve or reverse with combined liver-kidney transplantation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2012090

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  11 in total

1.  Cardiac abnormalities in primary hyperoxaluria.

Authors:  Farouk Mookadam; Travis Smith; Panupong Jiamsripong; Sherif E Moustafa; Carla G Monico; John C Lieske; Dawn S Milliner
Journal:  Circ J       Date:  2010-09-29       Impact factor: 2.993

Review 2.  Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics.

Authors:  Rachel N Carmody; Peter J Turnbaugh
Journal:  J Clin Invest       Date:  2014-08-08       Impact factor: 14.808

3.  DNA sequencing and expression of the formyl coenzyme A transferase gene, frc, from Oxalobacter formigenes.

Authors:  H Sidhu; S D Ogden; H Y Lung; B G Luttge; A L Baetz; A B Peck
Journal:  J Bacteriol       Date:  1997-05       Impact factor: 3.490

4.  Restrictive cardiomyopathy in a patient with primary hyperoxaluria type II.

Authors:  Matthias R Schulze; Rolf Wachter; Alexander Schmeisser; Rainer Fischer; Ruth H Strasser
Journal:  Clin Res Cardiol       Date:  2006-02-17       Impact factor: 5.460

5.  Identification and classification of Oxalobacter formigenes strains by using oligonucleotide probes and primers.

Authors:  H Sidhu; M Allison; A B Peck
Journal:  J Clin Microbiol       Date:  1997-02       Impact factor: 5.948

6.  Oxalate-degrading activity in Bifidobacterium animalis subsp. lactis: impact of acidic conditions on the transcriptional levels of the oxalyl coenzyme A (CoA) decarboxylase and formyl-CoA transferase genes.

Authors:  Silvia Turroni; Claudia Bendazzoli; Samuele C F Dipalo; Marco Candela; Beatrice Vitali; Roberto Gotti; Patrizia Brigidi
Journal:  Appl Environ Microbiol       Date:  2010-07-02       Impact factor: 4.792

7.  Formyl-CoA transferase encloses the CoA binding site at the interface of an interlocked dimer.

Authors:  Stefano Ricagno; Stefan Jonsson; Nigel Richards; Ylva Lindqvist
Journal:  EMBO J       Date:  2003-07-01       Impact factor: 11.598

8.  Characterization and heterologous expression of the oxalyl coenzyme A decarboxylase gene from Bifidobacterium lactis.

Authors:  Federica Federici; Beatrice Vitali; Roberto Gotti; Maria Rosalia Pasca; Silvia Gobbi; Ammon B Peck; Patrizia Brigidi
Journal:  Appl Environ Microbiol       Date:  2004-09       Impact factor: 4.792

Review 9.  Should liver transplantation be performed before advanced renal insufficiency in primary hyperoxaluria type 1?

Authors:  P Cochat; K Schärer
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

Review 10.  Oxalate-degrading microorganisms or oxalate-degrading enzymes: which is the future therapy for enzymatic dissolution of calcium-oxalate uroliths in recurrent stone disease?

Authors:  Ammon B Peck; Benjamin K Canales; Cuong Q Nguyen
Journal:  Urolithiasis       Date:  2015-12-08       Impact factor: 3.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.